COVID-19 Linked To Asthma, Seasonal Allergies

By Dennis Thompson HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 22, 2025.

via HealthDay

FRIDAY, Aug. 22, 2025 — COVID-19 infection might increase a person’s risk of developing asthma, seasonal allergies and long-lasting sinus problems, a new study says.

However, vaccination appears to reduce this risk, researchers report in the Journal of Allergy and Clinical Immunology.

“It is interesting to see that vaccination not only protects against the infection itself, but also appears to provide good protection against certain respiratory complications,” senior investigator Philip Curman, a researcher in medical epidemiology and biostatistics at Karolinska Institute in Sweden, said in a news release.

For the study, researchers compared nearly 974,000 people who’d been infected with COVID with more than 4.4 million people who’d been neither infected nor vaccinated. The records came from a major U.S. electronic health database.

Results showed that COVID patients had a 66% increased risk of developing asthma.

They also had a 74% higher risk of chronic sinus inflammation and a 27% increased risk of hay fever, researchers said.

However, infection did not increase risk of other diseases like eczema or esophageal inflammation, researchers siad.

“Our results suggest that COVID-19 can trigger type-2 inflammation in the airways, but not in other organs,” Curman said.

The team also compared healthy people against those vaccinated against COVID and found the opposite effect — risk of asthma was 32% lower against those who’d gotten the jab.

But when COVID patients were compared to those vaccinated against COVID, an even clearer effect was found.

People infected with COVID had more than twice the risk of asthma or sinus problems and 40% higher odds of hay fever, compared to those who’d been vaccinated.

However, researchers warned that the study could only show an association, not a cause-and-effect relationship, between COVID and airway problems.

Sources

  • Karolinska Institute, news release, Aug. 14, 2025
  • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords